Acute Myocardial Infarction
GLP-1s tied to better survival after PCI for heart attack in patients with diabetes
Among patients with diabetes who underwent PCI after an acute heart attack, those taking a GLP-1 had better survival rates than those not taking one, researchers reported.
Obesity-related heart attack deaths increased from 2007 to 2019
Deaths attributed to both acute heart attack and obesity rose between 2007 and 2019, according to findings from the CDC WONDER database presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.
Low adverse event rates at 1 month after PCI in ambulatory surgery centers
Medicare beneficiaries who underwent PCI at both ambulatory surgery centers and hospital outpatient departments had low rates of adverse outcomes at 30 days, researchers reported.
For many patients, ‘a major bleed is any bleed that happens to me’
Despite advances in anticoagulant therapies, bleeding remains a critical concern.
Lower fracture, higher cardiovascular risks seen with denosumab for patients on dialysis
Among adults with osteoporosis on dialysis, use of denosumab significantly lowered fracture risk compared with bisphosphonate use, but cardiovascular risk was increased, according to study data.
Colchicine does not improve outcomes in patients getting PCI after acute heart attack
WASHINGTON — Contradicting previous research, in a large trial of patients referred for PCI after acute MI, colchicine did not improve CV outcomes compared with placebo, according to the CLEAR SYNERGY (OASIS-9) trial presented at TCT 2024.
Early triple combination COPD therapy decreases exacerbations, cardiopulmonary events
Patients with COPD on budesonide/glycopyrrolate/formoterol fumarate within 30 days of an exacerbation had fewer future exacerbations and severe cardiopulmonary events, according to a study poster.